What’s the out‑of‑pocket price for a typical Tarceva prescription?
Tarceva (erlotinib) is usually sold in 100 mg capsules, 75 mg twice a day. A 30‑day supply costs about $2,000 – $2,500 without insurance. Prices vary by pharmacy and region; some sites show discounts of 10–20 % with coupons or discount cards [1].
Does insurance cover Tarceva, and what can you expect to pay?
Most commercial plans cover Tarceva, but copays can range from a few dollars to several hundred dollars per month, depending on the tier structure. Medicare Part D plans list Tarceva in the drug directory; patients in a formulary tier may pay a copay of $0–$25, while those on a non‑preferred tier may face 20–35 % coinsurance on the full price [2].
Are there patient assistance programs that lower the cost?
Pfizer offers a patient assistance program for eligible patients who meet income and insurance criteria. The program can cover 100 % of the drug cost, but requires a modest co‑payment of $30–$50 per month for a 30‑day supply, depending on the pharmacy used [3]. Some state Medicaid programs also cover Tarceva for qualifying patients.
What are the typical pharmacy price ranges?
Large chain pharmacies (CVS, Walgreens) list Tarceva at roughly $2,200 per month. Specialty pharmacies sometimes offer the drug for $2,400–$2,800, but they may require a prior authorization from the prescriber. Discount cards or coupons can bring the price down to about $1,800 in some cases [1].
Do generic versions of Tarceva exist, and when might they appear?
No generic erlotinib has been approved in the U.S. yet. The original patent for erlotinib expired in 2024, but the drug’s complex formulation and manufacturing process mean that generic competition is unlikely in the next few years. Patients may need to wait for a biosimilar or a cost‑effective alternative to emerge [4].
How does Tarceva’s price compare to other EGFR inhibitors?
Keytruda (pembrolizumab) costs about $6,000 per month for a 200 mg dose, while Tecentriq (atezolizumab) runs around $5,500. Tarceva remains the cheapest oral EGFR inhibitor but is still pricey compared to generic‑grade drugs for other cancers. Some clinicians recommend Tarceva when the tumor carries EGFR mutations and the patient’s insurance supports it, but price negotiations may favor newer agents with better reimbursement terms [5].
What factors drive Tarceva’s high cost?
The drug’s high research and development expenses, limited competition, and the cost of specialty pharmacy distribution contribute to its price. The manufacturer also sets a high list price to offset the cost of patient assistance programs and to maintain a strong market presence for a long‑term therapeutic agent [6].
Can you get a sample or free trial of Tarceva?
Most drug manufacturers no longer provide free samples of Tarceva for patients. Physicians can request a sample directly from the manufacturer, but approval is rare, and the quantity is usually limited to a few days of therapy. Patients are encouraged to discuss financial assistance or insurance coverage with their provider’s pharmacy team.
What’s the average monthly cost with insurance and assistance?
For a patient with a preferred formulary tier and no copay, the out‑of‑pocket cost can be under $50 per month. With standard copays (≈$30) and a small assistance co‑payment ($30–$50), the total out‑of‑pocket expense averages $80–$100 per month. These figures can double or triple for patients on higher tiers or with limited assistance [2][3].
What should patients ask their pharmacist or insurer?
- Is Tarceva on the preferred formulary?
- Can a lower‑tier co‑pay be negotiated?
- Are there available coupons or discount cards?
- What is the eligibility criteria for the patient assistance program?
Addressing these questions early can reduce the monthly cost from over $2,000 to a manageable range for most patients.
Sources
[1] GoodRx. Tarceva price list. https://www.goodrx.com/erlotinib-tarceva/price
[2] CMS. Medicare Part D drug list. https://www.cms.gov/Medicare/PrescriptionDrugCoverage/PartDDrugList
[3] Pfizer. Tarceva patient assistance program. https://www.pfizer.com/patient-support/financial-assistance/tarceva
[4] DrugBank. Erlotinib. https://go.drugbank.com/drugs/DB00319
[5] US News & World Report. Tarceva price. https://www.usnews.com/healthcare-provider-articles/price-of-tarceva
[6] StatPearls. Erlotinib (Tarceva). https://www.ncbi.nlm.nih.gov/books/NBK459480/